Guidelines for 131I-meta-iodobenzylguanidine therapy.
D019797:3-Iodobenzylguanidine / Q000627:therapeutic use*; D005060:Europe; D006801:Humans; D017599:Neuroectodermal Tumors / Q000175:diagnosis / Q000532:radiotherapy*; D009683:Nuclear Medicine / Q000592:standards; D018579:Patient Selection; D019275:Radiopharmaceuticals / Q000627:therapeutic use; D011878:Radiotherapy / Q000379:methods / Q000592:standards*; D012955:Societies, Medical / Q000592:standards; D016896:Treatment Outcome
D019275:Radiopharmaceuticals; D019797:3-Iodobenzylguanidine